You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 27, 2024

Litigation Details for UCB, Inc. v. Cipla Limited (D. Del. 2021)

✉ Email this page to a colleague

« Back to Dashboard

UCB, Inc. v. Cipla Limited (D. Del. 2021)

Docket	⤷ Try a Trial	Date Filed	2021-08-26
Court	District Court, D. Delaware	Date Terminated
Cause	35:271 Patent Infringement	Assigned To	Jennifer L. Hall
Jury Demand	None	Referred To
Parties	CIPLA USA INC.
Patents	7,022,014; 8,217,033; 8,809,322; 9,289,432; 9,687,495
Attorneys	Peter L. Giunta
Firms	Morris James LLP
Link to Docket	External link to docket

Small Molecule Drugs cited in UCB, Inc. v. Cipla Limited

The small molecule drug covered by the patents cited in this case is ⤷ Try a Trial .

Biologic Drugs cited in UCB, Inc. v. Cipla Limited

The biologic drug covered by the patents cited in this case is ⤷ Try a Trial .

Details for UCB, Inc. v. Cipla Limited (D. Del. 2021)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Date Filed	Document No.	Description	Snippet	Link To Document
2022-12-16	111	Notice of Service	Non-Obviousness Supporting the Validity of U.S. Patent Nos. 8,217,033, 8,809,322, 9,289,432, and 9,687,495; and…Non-Obviousness Supporting the Validity of U.S. Patent Nos. 8,217,033, 8,809,322, 9,289,432, and 9,687,495 filed… 26 August 2021 1:21-cv-01229 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2023-02-15	117	Notice of Service	Hugh Smyth Regarding the Validity of U.S. Patent Nos. 8,217,033 and 8,809,322 filed by Hananja EHF, UCB … 26 August 2021 1:21-cv-01229 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2023-03-15	119	Notice of Service	Non-Obviousness Supporting the Validity of U.S. Patent Nos. 8,217,033 and 8,809,322; and (2) Reply Expert Report…Non-Obviousness Supporting the Validity of U.S. Patent Nos. 8,217,033 and 8,809,322 filed by Hananja EHF, UCB … 26 August 2021 1:21-cv-01229 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2023-07-05	136	- Transcript	10, 25:10 18:11, 20:7, 22:14 23:15 …much, given my review 8 of the patents, so you can take that for what 9 …reports cited 25 by the parties and patents, and I do think Case 1:21-cv-01229-JLH Document… N 20:20 patents [2] - 16:8, 20:5… 26 August 2021 1:21-cv-01229 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2021-08-26	4	Patent/Trademark Report to Commissioner of Patents	the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,217,033 B2 ;8,809,322 B2 ;9,289,432… 26 August 2021 1:21-cv-01229 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.